SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-23-003501
Filing Date
2023-08-29
Accepted
2023-08-29 16:28:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3325
  Complete submission text file 0001950047-23-003501.txt   4755
Mailing Address C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, 5TH FLR. SOUTH SAN FRANCISCO CA 94080
Business Address
Hoey Timothy (Reporting) CIK: 0001553333 (see all company filings)

Type: 144

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40656 | Film No.: 231222263
SIC: 2836 Biological Products, (No Diagnostic Substances)